Where does InnoMed Healthscience, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), InnoMed Healthscience, Inc. ranks #10,355 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does InnoMed Healthscience, Inc. hold?

InnoMed Healthscience, Inc. holds 30 US utility patents granted between 2018 and 2025, spanning 2 technology areas.

What is InnoMed Healthscience, Inc.'s Innovation Score?

InnoMed Healthscience, Inc. has an Innovation Score of 18.6 out of 100 (5th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is InnoMed Healthscience, Inc.'s patent grant rate increasing or decreasing?

InnoMed Healthscience, Inc.'s recent grant velocity is -88% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for InnoMed Healthscience, Inc.'s patents?

InnoMed Healthscience, Inc.'s patents average 3.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the InnoMed Healthscience, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

InnoMed Healthscience, Inc.

Q: What technology areas does InnoMed Healthscience, Inc. focus on?

InnoMed Healthscience, Inc.'s top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 3 patents, ranking #1,777 of 3,490 assignees active in that subclass. Grants appear in 2 CPC subclasses total.

USPTO PatentsView assignee record - 30 granted patents across 2 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Innomed ranks #10,355 of 49,997 tracked US assignees by granted-patent volume, with 30 patents across 2 technology areas.

#10,355
of 49,997 US assignees by volume: 5th percentile
by Innovation Score (18.6/100): 3.0
avg claims per patent: -88%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R10355 · US Corporation #10,355 · 30 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-LOW · CLAIMS-SPARSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 30 grants
UPPER-Q #10,355/49,997
PHOTO-FINISH Included Health
CPC-NARROW A61M · 2 areas
INNOV-LOW 18.6/100
CLAIMS-SPARSE 3.0 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -88% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Included Health, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Innomed’s 18.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.9 pts (64%) Velocity 0.0 pts (0%) Breadth 5.0 pts (27%) Claim depth 1.8 pts (10%)

Qualcomm Incorporated · highest

85
Presidio Pharmaceuti… · near

19
Pierpoint · near

19
InnoMed Healthscience · this assignee

19
Shenzhen Impetus… · near

19
Paramount Automotive… · near

19
3D Lighting… · lowest

7

What this shows Innomed's Innovation Score is 18.6/100 (5th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Innomed?

Each dot is one of Innomed’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Innomed’s own 3.0 claims/patent is at or below the 14.5 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Innomed vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Innomed's grants concentrate

InnoMed Healthscience, Inc. is a focused PatentsView assignee: 2 CPC subclasses with 10% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2019 (25 grants) versus a trough of 1 in 2018. By volume, Innomed sits between Included Health, Inc. and J. VAN Walraven Holding B.V..

Included Health

30
Industry Academic…

30
Institut Jean Pao…

30
Inhibrx

30
Innovega

30
Intuity Medical

30
Invincea

30
J VAN Walraven Ho…

30
Innomed Healthsci… ◀

30

What this shows InnoMed holds 30 patents at rank #10,356, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near InnoMed

By rank, the assignees closest to #10,356 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in InnoMed's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for InnoMed, neither rank-band nor same-CPC leaders (those blocks stay above). In A61M (Devices FOR Introducing Media Into), InnoMed ranks #1,777 of 3,490 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (19 here).

Shenzhen Impetus Technology Co., Ltd. 19 Pierpoint, Inc. 19 Presidio Pharmaceuticals, Inc. 19 Paramount Automotive Restyling Inc. 19

Innomed's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

19 5th percentile higher than 5% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

InnoMed Healthscience, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	1	3.3%
2019	25	83.3%
2020	2	6.7%
2021	1	3.3%
2025partial year	1	3.3%

Which technologies does InnoMed Healthscience, Inc. patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 3

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 1

Top 2 of 2 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

InnoMed Healthscience, Inc.'s patent record in context - here's where to go next.

InnoMed Healthscience, Inc.'s lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 10% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #10,355 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare InnoMed Healthscience, Inc. against Included Health, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 18.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.